FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2804760894> ?p ?o ?g. }

• W2804760894 endingPage "813e" @default.
• W2804760894 startingPage "805e" @default.
• W2804760894 abstract "Background: The use of hormone therapy (tamoxifen and aromatase inhibitors) has been shown to increase venous thromboembolism. As breast cancer patients undergoing microsurgical breast reconstruction are often receiving hormone therapy, it is unclear whether this increased thrombotic risk is associated with increased flap loss. Methods: A retrospective review was performed on patients undergoing abdominally based microsurgical breast reconstruction at an academic institution from 2004 to 2015. Patients were divided by use of hormone therapy at the time of surgery. Complication rates, including complete or partial flap loss and overall complications, were compared and analyzed using univariate and logistic regression models. Results: Among a total of 853 patients (1253 flaps), 193 patients (269 flaps) were receiving hormone therapy and 660 patients (984 flaps) were not. Patients on hormone therapy had higher rates of previous breast surgery, advanced cancer stage, chemoradiation before reconstruction, and delayed and unilateral reconstruction. There were no statistically significant differences between hormone therapy patients and nontherapy patients in complete flap loss (1.0 percent versus 1.1 percent) and partial flap loss (2.2 percent versus 1.5 percent). Hypertension and previous breast surgery were the only independent risk factors for minor complications (adjusted OR, 2.1; 95 percent CI, 1.3 to 3.6; p = 0.005; and adjusted OR, 1.8; 95 percent CI, 1.2 to 2.7; p = 0.009, respectively) and overall complications (adjusted OR, 2.2; 95 percent CI, 1.3 to 3.7; p = 0.004; and adjusted OR, 1.9; 95 percent CI, 1.3 to 3.0; p = 0.003, respectively). Conclusions: Hormone therapy was not associated with a higher incidence of complete or partial flap loss or overall complications. The authors propose an individualized approach to the preoperative cessation of tamoxifen or aromatase inhibitors. CLINICAL QUESTION/LEVEL OF EVIDENCE: Therapeutic, III." @default.
• W2804760894 created "2018-06-01" @default.
• W2804760894 creator A5003401807 @default.
• W2804760894 creator A5003447993 @default.
• W2804760894 creator A5009059223 @default.
• W2804760894 creator A5015767701 @default.
• W2804760894 creator A5041984314 @default.
• W2804760894 creator A5072901591 @default.
• W2804760894 creator A5076625608 @default.
• W2804760894 creator A5083945405 @default.
• W2804760894 creator A5087440227 @default.
• W2804760894 date "2018-06-01" @default.
• W2804760894 modified "2023-10-11" @default.
• W2804760894 title "Does Hormone Therapy Use Increase Perioperative Complications in Abdominally Based Microsurgical Breast Reconstruction?" @default.
• W2804760894 cites W1531964529 @default.
• W2804760894 cites W1541363229 @default.
• W2804760894 cites W1541820635 @default.
• W2804760894 cites W1562190372 @default.
• W2804760894 cites W1598892184 @default.
• W2804760894 cites W175672528 @default.
• W2804760894 cites W1862117336 @default.
• W2804760894 cites W1961026612 @default.
• W2804760894 cites W1976318219 @default.
• W2804760894 cites W1995374012 @default.
• W2804760894 cites W1998034469 @default.
• W2804760894 cites W1999924570 @default.
• W2804760894 cites W2004218393 @default.
• W2804760894 cites W2015473392 @default.
• W2804760894 cites W2015930390 @default.
• W2804760894 cites W2017789245 @default.
• W2804760894 cites W2018610111 @default.
• W2804760894 cites W2052508365 @default.
• W2804760894 cites W2058052849 @default.
• W2804760894 cites W2058358739 @default.
• W2804760894 cites W2068318554 @default.
• W2804760894 cites W2075932321 @default.
• W2804760894 cites W2087391502 @default.
• W2804760894 cites W2090476016 @default.
• W2804760894 cites W2099535971 @default.
• W2804760894 cites W2118728607 @default.
• W2804760894 cites W2134393064 @default.
• W2804760894 cites W2143500476 @default.
• W2804760894 cites W2146913888 @default.
• W2804760894 cites W2161977537 @default.
• W2804760894 cites W2162376045 @default.
• W2804760894 cites W2166969772 @default.
• W2804760894 cites W2227853740 @default.
• W2804760894 cites W2288573156 @default.
• W2804760894 cites W2321114481 @default.
• W2804760894 cites W2333363028 @default.
• W2804760894 cites W2349457619 @default.
• W2804760894 cites W2410559179 @default.
• W2804760894 cites W2586728125 @default.
• W2804760894 doi "https://doi.org/10.1097/prs.0000000000004359" @default.
• W2804760894 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30817671" @default.
• W2804760894 hasPublicationYear "2018" @default.
• W2804760894 type Work @default.
• W2804760894 sameAs 2804760894 @default.
• W2804760894 citedByCount "10" @default.
• W2804760894 countsByYear W28047608942019 @default.
• W2804760894 countsByYear W28047608942020 @default.
• W2804760894 countsByYear W28047608942021 @default.
• W2804760894 countsByYear W28047608942022 @default.
• W2804760894 countsByYear W28047608942023 @default.
• W2804760894 crossrefType "journal-article" @default.
• W2804760894 hasAuthorship W2804760894A5003401807 @default.
• W2804760894 hasAuthorship W2804760894A5003447993 @default.
• W2804760894 hasAuthorship W2804760894A5009059223 @default.
• W2804760894 hasAuthorship W2804760894A5015767701 @default.
• W2804760894 hasAuthorship W2804760894A5041984314 @default.
• W2804760894 hasAuthorship W2804760894A5072901591 @default.
• W2804760894 hasAuthorship W2804760894A5076625608 @default.
• W2804760894 hasAuthorship W2804760894A5083945405 @default.
• W2804760894 hasAuthorship W2804760894A5087440227 @default.
• W2804760894 hasConcept C121608353 @default.
• W2804760894 hasConcept C126322002 @default.
• W2804760894 hasConcept C141071460 @default.
• W2804760894 hasConcept C144301174 @default.
• W2804760894 hasConcept C167135981 @default.
• W2804760894 hasConcept C2777176818 @default.
• W2804760894 hasConcept C2777757722 @default.
• W2804760894 hasConcept C2780275930 @default.
• W2804760894 hasConcept C2781001896 @default.
• W2804760894 hasConcept C31174226 @default.
• W2804760894 hasConcept C38180746 @default.
• W2804760894 hasConcept C530470458 @default.
• W2804760894 hasConcept C71924100 @default.
• W2804760894 hasConceptScore W2804760894C121608353 @default.
• W2804760894 hasConceptScore W2804760894C126322002 @default.
• W2804760894 hasConceptScore W2804760894C141071460 @default.
• W2804760894 hasConceptScore W2804760894C144301174 @default.
• W2804760894 hasConceptScore W2804760894C167135981 @default.
• W2804760894 hasConceptScore W2804760894C2777176818 @default.
• W2804760894 hasConceptScore W2804760894C2777757722 @default.
• W2804760894 hasConceptScore W2804760894C2780275930 @default.
• W2804760894 hasConceptScore W2804760894C2781001896 @default.
• W2804760894 hasConceptScore W2804760894C31174226 @default.
• W2804760894 hasConceptScore W2804760894C38180746 @default.

• next